Eutilex.Co.Ltd (263050) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.083x

Based on the latest financial reports, Eutilex.Co.Ltd (263050) has a cash flow conversion efficiency ratio of -0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.41 Billion ≈ $-1.63 Million USD) by net assets (₩28.91 Billion ≈ $19.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Eutilex.Co.Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Eutilex.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 263050 liabilities breakdown for a breakdown of total debt and financial obligations.

Eutilex.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eutilex.Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Conduril - Engenharia S.A LS:CDU	N/A
Korea SE Corp KQ:101670	-0.024x
JPMorgan American Investment Trust LSE:JAM	0.003x
Kalyani Forge Limited NSE:KALYANIFRG	-0.027x
Hermana Holding ASA OL:HERMA	-0.043x
SCGM Bhd KLSE:7247	-0.031x
Brilliant Earth Group Inc NASDAQ:BRLT	0.090x
Republic Power Group Limited Class A Ordinary Shares NASDAQ:RPGL	-0.024x

Annual Cash Flow Conversion Efficiency for Eutilex.Co.Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Eutilex.Co.Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Eutilex.Co.Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩39.94 Billion ≈ $27.07 Million	₩-21.40 Billion ≈ $-14.50 Million	-0.536x	-26.63%
2023-12-31	₩60.44 Billion ≈ $40.96 Million	₩-25.58 Billion ≈ $-17.33 Million	-0.423x	-24.17%
2022-12-31	₩87.75 Billion ≈ $59.47 Million	₩-29.90 Billion ≈ $-20.26 Million	-0.341x	+13.88%
2021-12-31	₩68.38 Billion ≈ $46.34 Million	₩-27.06 Billion ≈ $-18.34 Million	-0.396x	-30.05%
2020-12-31	₩58.51 Billion ≈ $39.65 Million	₩-17.80 Billion ≈ $-12.07 Million	-0.304x	-42.14%
2019-12-31	₩62.83 Billion ≈ $42.58 Million	₩-13.45 Billion ≈ $-9.11 Million	-0.214x	-62.31%
2018-12-31	₩77.49 Billion ≈ $52.52 Million	₩-10.22 Billion ≈ $-6.93 Million	-0.132x	-24.07%
2017-12-31	₩51.13 Billion ≈ $34.65 Million	₩-5.44 Billion ≈ $-3.68 Million	-0.106x	+25.20%
2016-12-31	₩25.87 Billion ≈ $17.53 Million	₩-3.68 Billion ≈ $-2.49 Million	-0.142x	--

About Eutilex.Co.Ltd

KQ:263050 Korea Biotechnology

Market Cap

$23.94 Million

₩35.32 Billion KRW

Market Cap Rank

#24464 Global

#1805 in Korea

Share Price

₩959.00

Change (1 day)

+29.95%

52-Week Range

₩683.00 - ₩2740.00

All Time High

₩41553.86